IGM Biosciences, Inc.·4

Dec 20, 8:08 PM ET

Schwarzer Fred 4

4 · IGM Biosciences, Inc. · Filed Dec 20, 2022

Insider Transaction Report

Form 4
Period: 2022-12-16
Schwarzer Fred
DirectorCEO and President
Transactions
  • Sale

    Common Stock

    2022-12-16$18.77/sh7,955$149,35224,774 total
  • Sale

    Common Stock

    2022-12-16$19.36/sh4,414$85,45320,360 total
Holdings
  • Common Stock

    (indirect: See footnote)
    196,718
Footnotes (4)
  • [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]This transaction was executed in multiple trades at prices ranging from $18.29 to $19.289. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  • [F3]This transaction was executed in multiple trades at prices ranging from $19.30 to $19.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  • [F4]The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION